CAT Catco Reinsurance Opportunities Fund Limited

RNS No 1358v
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC


                            DEALINGS BY DIRECTORS

1)   NAME OF COMPANY

     CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC

2)   NAME OF DIRECTOR

     SIR AARON KLUG

3)   Please state whether notification indicates that it is in
     respect of holding of the Director named in 2 above
     or holding of that person's spouse or children under
     the age of 18 or in respect of a non-beneficial interest

     DIRECTOR

4)   Name of the registered holder(s) and, if more than
     one holder, the number of shares held by each of 
     them. (If notified)

     SIR AARON KLUG

5)   Please state whether notification relates to a
     person(s) connected with the Director named in 2
     above and identify the connected person(s)

     DR. ADAM BRIAN JOSEPH KLUG (SON)
     DR. DAVID RUPERT KLUG (SON)

6)   Please state the nature of the transaction. For
     PEP transactions please indicate whether
     general/single co PEP and if discretionary/non
     discretionary

     TRANSFER FOR NO CONSIDERATION FROM SIR AARON KLUG TO
     ADAM KLUG -  39,219 SHARES
     DAVID KLUG - 39,218 SHARES

7)   Number of shares/amount of
     stock acquired

N/A

8)   ( N/A %)
    of issued Class

9)   Number of shares/amount
     of stock disposed

     78,437

10)  (0.354%)
    of issued Class

11)  Class of security

     ORDINARY SHARES

12)  Price per share

     NIL

13)  Date of transaction

     6 JUNE 1997

14)  Date company informed

     9 JUNE 1997

15)  Total holding following this notification

     500

16)  Total percentage holding of issued class following 
     this notification      

     0.002%

      IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE COMPLETE 
                              THE FOLLOWING BOXES

17)  Date of grant

N/A

18)  Period during which or date on which exercisable

N/A

19)  Total amount paid (if any) for grant of the option

N/A

20)  Description of shares or debentures involved:
     class, number.

N/A

21)  Exercise price (if fixed at time of grant) or indication
     that price is to be fixed at time of exercise

N/A

22)  Total number of shares or debentures over which
     options held following this notification

N/A

23)  Any additional information

     TRANSFEREES HAVE EXECUTED DEEDS OF ADHERENCE
     TO DIRECTOR'S LOCK-UP AGREEMENT

24)  Name of contact and telephone number for queries

     A M NIXON 
     01763-263233


25)  Name and signature of authorised company official
     responsible for making this notification

     Date of Notification..8 JULY 1997..............................


END

Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024

Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024